Croda and AAHI partner to drive innovation in vaccine development
The exclusive agreement between AAHI and Croda includes a collaborative effort in research and development
The exclusive agreement between AAHI and Croda includes a collaborative effort in research and development
Upon completion of successful human trials and regulatory approval, the joint venture's goal is to start delivering the second-generation vaccine in 2022 as soon as is practically possible
Subscribe To Our Newsletter & Stay Updated